Showing results (311-320 of 385) with videos related to
Sort By:
Pageof 39
Neurorehabilitation and Neural Repair|March 1, 2024
Prevalence and Associated Clinical Characteristics of Walking-Related Motor, Cognitive, and Fatigability in Progressive Multiple Sclerosis: Baseline Results From the CogEx StudyCintia Ramari, Mieke D'hooge, Ulrik Dalgas, et al.Journal of Clinical Medicine|September 9, 2022
Quality of Life Changes in Early-Onset Multiple Sclerosis: A 4-Year Follow-Up StudyLaura Rosa, Maria Petracca, Antonio Carotenuto, et al.European Journal of Neurology|May 2, 2025
Identifying neuropsychological phenotypes in multiple sclerosis using latent profile analysisAntonio Luca Spiezia, Giuseppe Pontillo, Fabrizia Falco, et al.Journal of Neurology|November 27, 2022
Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosisPaolo Preziosa, Maria A Rocca, Elisabetta Pagani, et al.Journal of the Neurological Sciences|December 7, 2025
Plasma neurofilament light chain to evaluate response during cladribine treatment in multiple sclerosisValerio Nicolella, Marco Varelli, Stefania Fasano, et al.Journal of the Neurological Sciences|July 4, 2024
Clinical utility of the Lumipulse™ immunoassay for plasma neurofilament light chain in multiple sclerosisValerio Nicolella, Mariano Fiorenza, Isabel Monteiro, et al.Neurology(R) Neuroimmunology & Neuroinflammation|March 7, 2020
Impact of treatment on cellular immunophenotype in MS: A cross-sectional studyMaria Cellerino, Federico Ivaldi, Matteo Pardini, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 16, 2024
Cognitive rehabilitation effects on grey matter volume and Go-NoGo activity in progressive multiple sclerosis: results from the CogEx trialMaria A Rocca, Paola Valsasina, Francesco Romanò, et al.European Journal of Neurology|May 8, 2023
Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis: Who gains from it?Irene Schiavetti, Matilde Inglese, Jessica Frau, et al.Journal of Clinical Medicine|December 19, 2020
Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the IcebergNicola Capasso, Raffaele Palladino, Emma Montella, et al.Pageof 39